1. Intermittent chemotherapy for metastatic hormone refractory prostate cancer 
Amy M. Lin, Charles J. Ryan, Eric J. Small 
Critical Reviews in Oncology / Hematology 
Volume 61, Issue 3, Pages (March 2007)
DOI: /j.critrevonc
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions

2. Fig. 1
Intermittent vs. continuous chemotherapy for breast cancer. Study schema for Tormey et al. [7]. Abbreviations—Cyt: cyclophosphamide, MTX: methotrexate, 5FU: 5-fluorouracil, VCR: vincristine, Pred: prednisone, and Adria: adriamycin.
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions

3. Fig. 2
Intermittent vs. continuous chemotherapy for breast cancer. Study schema for Coates et al. [8]. Abbreviations—Adria: adriamycin, Cyt: cyclophosphamide, MTX: methotrexate, 5FU: 5-fluorouracil, Pred: prednisone, CR: complete response, PR: partial response, and SD: stable disease.
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions

4. Fig. 3
Intermittent vs. continuous chemotherapy for breast cancer. Study schema for Muss et al. [10]. Abbreviations—Cyt: cyclophosphamide, Adria: adriamycin, 5FU: 5-fluorouracil, MTX: methotrexate, CR: complete response, PR: partial response, and SD: stable disease.
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions

5. Fig. 4
Intermittent vs. continuous chemotherapy for breast cancer. Study schema for the French Epirubicin Study [11]. Abbreviations—Cyt: cyclophosphamide, Epi: epirubucin, 5FU: 5-fluorouracil, CR: complete response, PR: partial response, and SD: stable disease.
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions

6. Fig. 5
Intermittent vs. continuous chemotherapy for colorectal cancer. Study schema for Maughan et al. [12]. Abbreviations—5FU: 5-fluorouracil, CR: complete response, PR: partial response, and SD: stable disease.
Critical Reviews in Oncology / Hematology  , DOI: ( /j.critrevonc )
Copyright © 2006 Elsevier Ireland Ltd Terms and Conditions